BR0212254A - Composição farmaceutica - Google Patents

Composição farmaceutica

Info

Publication number
BR0212254A
BR0212254A BR0212254-5A BR0212254A BR0212254A BR 0212254 A BR0212254 A BR 0212254A BR 0212254 A BR0212254 A BR 0212254A BR 0212254 A BR0212254 A BR 0212254A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
angiotensin
administering
separately
same time
Prior art date
Application number
BR0212254-5A
Other languages
English (en)
Inventor
Toshio Sada
Toshimori Inaba
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of BR0212254A publication Critical patent/BR0212254A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA". A presente invenção refere-se a composições medicinais para administrar um antagonista do receptor da angiotensina II e um inibidor de ACAT, ou ao mesmo tempo ou separadamente em um certo intervalo.
BR0212254-5A 2001-08-28 2002-08-27 Composição farmaceutica BR0212254A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001257435 2001-08-28
PCT/JP2002/008629 WO2003020315A1 (fr) 2001-08-28 2002-08-27 Compositions medicinales contenant un antagoniste du recepteur d'angiotensine ii

Publications (1)

Publication Number Publication Date
BR0212254A true BR0212254A (pt) 2004-10-19

Family

ID=19085097

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212254-5A BR0212254A (pt) 2001-08-28 2002-08-27 Composição farmaceutica

Country Status (17)

Country Link
US (1) US20040198788A1 (pt)
EP (1) EP1421953A4 (pt)
KR (1) KR20040032969A (pt)
CN (1) CN1589154A (pt)
AU (1) AU2002328569B9 (pt)
BR (1) BR0212254A (pt)
CA (1) CA2459017A1 (pt)
CO (1) CO5560583A2 (pt)
HU (1) HUP0401696A2 (pt)
IL (1) IL160438A0 (pt)
MX (1) MXPA04001878A (pt)
NO (1) NO20041291L (pt)
NZ (1) NZ531346A (pt)
PL (1) PL368843A1 (pt)
RU (1) RU2004105965A (pt)
WO (1) WO2003020315A1 (pt)
ZA (1) ZA200401603B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1604664A4 (en) * 2003-01-31 2006-12-27 Sankyo Co MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS AND BLOOD HIGH PRESSURE
US20090226420A1 (en) * 2005-11-10 2009-09-10 Elizabeth Hauser Methods of Determining the Risk of Developing Coronary Artery Disease
KR101345876B1 (ko) * 2012-01-31 2013-12-30 인제대학교 산학협력단 피마사르탄을 함유하는 세포, 조직 또는 장기 보존용 조성물
CN112979617A (zh) * 2019-12-17 2021-06-18 中国科学院苏州纳米技术与纳米仿生研究所 一种厄贝沙坦哌嗪盐及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8705837A1 (es) * 1985-01-10 1987-05-16 Tanabe Seiyaku Co Un procedimiento para la preparacion de derivados de naftaleno.
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
EP0421441B1 (en) * 1989-10-06 1995-01-25 Fujirebio Inc. Pantothenic acid derivatives
DE122010000024I1 (de) * 1990-02-19 2010-07-08 Novartis Ag Acylverbindungen
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
GB9025509D0 (en) * 1990-11-23 1991-01-09 Fujisawa Pharmaceutical Co New amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
EP0559898B1 (en) * 1990-11-26 1996-05-08 Taisho Pharmaceutical Co. Ltd Anilide derivative
US5614519A (en) * 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
FI112942B3 (fi) * 1991-02-21 2012-03-13 Daiichi Sankyo Co Ltd Menetelmä kohonneen verenpaineen hoitoon ja ennaltaehkäisyyn käyttökelpoisten 4'-(1H-imidatsol-1-yylimetyyli)-1,1' -bifenyylijohdannaisten valmistamiseksi
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
JP3720395B2 (ja) * 1994-09-20 2005-11-24 京都薬品工業株式会社 新規ヘテロ環誘導体、その製造方法およびその医薬用途
KR100388345B1 (ko) * 1995-10-05 2004-03-30 교토 야쿠힝 고교 가부시키가이샤 신규헤테로시클릭유도체및이것의의약용도
FR2741619B1 (fr) * 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
CA2197364A1 (en) * 1996-02-15 1997-08-16 Toshikazu Suzuki Phenol compound and process for preparing the same
JPH11228416A (ja) * 1997-10-23 1999-08-24 Takeda Chem Ind Ltd 脂質低下剤
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19916108C1 (de) * 1999-04-09 2001-01-11 Aventis Pharma Gmbh Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
WO2002087580A1 (fr) * 2001-04-25 2002-11-07 Takeda Chemical Industries, Ltd. Promoteurs d'expression d'abc

Also Published As

Publication number Publication date
AU2002328569B9 (en) 2005-10-27
ZA200401603B (en) 2004-10-19
CN1589154A (zh) 2005-03-02
IL160438A0 (en) 2004-07-25
NZ531346A (en) 2005-10-28
KR20040032969A (ko) 2004-04-17
CO5560583A2 (es) 2005-09-30
EP1421953A4 (en) 2004-09-15
EP1421953A1 (en) 2004-05-26
NO20041291D0 (no) 2004-03-26
PL368843A1 (en) 2005-04-04
CA2459017A1 (en) 2003-03-13
AU2002328569B2 (en) 2005-09-22
MXPA04001878A (es) 2004-06-15
HUP0401696A2 (hu) 2004-11-29
NO20041291L (no) 2004-05-27
WO2003020315A1 (fr) 2003-03-13
RU2004105965A (ru) 2005-05-10
US20040198788A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
BR0114410A (pt) Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade
BR0317392A (pt) Formulação não-higroscópica incluindo uma droga higroscópica
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
BRPI0410933A (pt) novos antagonistas do receptor p2x7 e seu uso
PT845989E (pt) Composicao de farmacos para aliviar a dor
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
AU3652102A (en) Compounds and their uses
BR0210078A (pt) Composto, uso do mesmo, e, formulação farmacêutica
MY134568A (en) Cb2 receptor agonists
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
BR9713147A (pt) Benzamidoaldeìdo, uso do mesmo, benzamida, e, preparação medicamentosa para administração oral, parenteral ou intraperitoneal.
BR0215042A (pt) fenil-naftalenos substituìdos como agentes estrogênicos
CY1108725T1 (el) Συνδυασμος ανταγωνιστου-nmda και αναστολεων ακετυλοχολινεστερασης δια την θεραπειαν της νοσου alzheimer
BR0213477A (pt) Grânulos orais e composição farmacêutica escoável e dispersìvel
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BRPI0407097A (pt) Antagonista do casr
BR9909138A (pt) Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda
SE0101932D0 (sv) Pharmaceutical combinations
BRPI0412919A (pt) combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
SE9802208D0 (sv) Novel compounds
BR0212931A (pt) Composição farmacêutica de liberação prolongada contendo metformina
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010.